Fate Therapeutics Receives $40,200,000 New Financing Round

  • Feed Type
  • Date
    10/1/2013
  • Company Name
    Fate Therapeutics
  • Mailing Address
    3535 General Atomics Court San Diego, CA 92121
  • Company Description
    The Fate Therapeutics (NASDAQ: FATE) platform focuses on both regenerative and reprogramming medicine. Fate’s regenerative medicine platform involves developing drugs that awaken adult stem cells in the body to repair damaged cells and tissues.
  • Website
    http://www.fatetherapeutics.com
  • Transaction Type
    IPO
  • Transaction Amount
    $40,200,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

By posting a comment, you agree to our terms and conditions.